abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip
otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea
none none solution for i.v. infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - 0.9% sodium chloride - solution for i.v. infusion - none
fluidex 10 10g/ 100ml (10% w/v) solution for iv infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - 10% dextrose in water - solution for iv infusion - 10g/ 100ml (10% w/v)
ubit 100 mg tablet
otsuka (phils.) pharmaceutical inc.; distributor: otsuka (phils.) pharmaceutical inc. - 13c-urea - tablet - 100 mg
norsalin d 50mg/ 9 mg per ml (5%w/v / 0.9% w/v solution for iv infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - 5% dextrose in 0.9% sodium chloride - solution for iv infusion - 50mg/ 9 mg per ml (5%w/v / 0.9% w/v
dextrosol 5 50mg/ ml (5% w/v) solution for i.v. infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - dextrose in water (5% ) - solution for i.v. infusion - 50mg/ ml (5% w/v)
fluidex 5 50 mg/ml (5% w/v) solution for iv infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - 5% dextrose in water - solution for iv infusion - 50 mg/ml (5% w/v)
ciproquin 2mg/ml solution for intravenous infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - ciprofloxacin - solution for intravenous infusion - 2mg/ml
elemune 200 mg/ml (20% w/v) solution for iv infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - l-alanyl-l-glutamine - solution for iv infusion - 200 mg/ml (20% w/v)
aarel 100ml (320mg, 600mg, 40mg, 27mg) solution for i.v. infusion
otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - lactated ringer's solution - solution for i.v. infusion - 100ml (320mg, 600mg, 40mg, 27mg)